Stephen R Rapp1, Jose A Luchsinger2,3, Laura D Baker4, George L Blackburn5, Helen P Hazuda6, Kathryn E Demos-McDermott7, Robert W Jeffery8, Jeffrey N Keller9, Jeanne M McCaffery7, Nicholas M Pajewski10, Mary Evans11, Thomas A Wadden12, Steven E Arnold13, Mark A Espeland10. 1. Department of Psychiatry and Behavioral Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 2. Department of Medicine, Columbia University Medical Center, New York, New York. 3. Department of Epidemiology, Columbia University Medical Center, New York, New York. 4. Department of Internal Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 5. Center for the Study of Nutrition Medicine, Beth Israel Deaconess Medical Center, Division of Nutrition, Harvard Medical School, Boston, Massachusetts. 6. Department of Medicine, University of Texas Health Sciences Center, San Antonio, Texas. 7. Department of Psychiatry and Human Behavior, Miriam Hospital and Alpert School of Medicine, Brown University, Providence, Rhode Island. 8. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota. 9. Pennington Biomedical Research Center, Baton Rouge, Louisiana. 10. Department of Biostatistical Sciences, School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 11. Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. 12. Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania. 13. Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Charleston, Massachusetts.
Abstract
OBJECTIVES: To assess whether randomization to 10 years of lifestyle intervention to induce and maintain weight loss improves cognitive function. DESIGN: Randomized controlled clinical trial. SETTING: Data obtained as part of the Action for Health in Diabetes (Look AHEAD) trial (NCT00017953) and Look AHEAD Continuation study (U01 DK057136-15). PARTICIPANTS: Overweight and obese individuals with type 2 diabetes mellitus aged 45 to 76 (N = 3,751). INTERVENTION: Intensive lifestyle intervention (ILI) for weight loss through reduced caloric intake and increased physical activity compared with a control condition of diabetes support and education (DSE). MEASUREMENTS: Certified examiners who were masked to intervention assignment administered a standard battery of cognitive function tests (Modified Mini-Mental State Examination, Rey Auditory Verbal Learning Test, Digit Symbol Coding, Trail-Making Test, Modified Stroop Color-Word Test) to participants 10 to 13 years after enrollment. RESULTS: Assignment to lifestyle intervention was not associated with significantly different overall (P = .10) or domain-specific (all P > .10) cognitive function than assignment to diabetes support and education. Results were fairly consistent across prespecified groups, but there was some evidence of trends for differential intervention effects showing modest harm in ILI in participants with greater body mass index and in individuals with a history of cardiovascular disease. Cognitive function was not associated with changes in weight or fitness (all P > .05). CONCLUSION:A long-term behavioral weight loss intervention for overweight and obese adults with diabetes mellitus was not associated with cognitive benefit. Trial Registration clinicaltrials.gov Identifier: NCT00017953.
RCT Entities:
OBJECTIVES: To assess whether randomization to 10 years of lifestyle intervention to induce and maintain weight loss improves cognitive function. DESIGN: Randomized controlled clinical trial. SETTING: Data obtained as part of the Action for Health in Diabetes (Look AHEAD) trial (NCT00017953) and Look AHEAD Continuation study (U01 DK057136-15). PARTICIPANTS: Overweight and obese individuals with type 2 diabetes mellitus aged 45 to 76 (N = 3,751). INTERVENTION: Intensive lifestyle intervention (ILI) for weight loss through reduced caloric intake and increased physical activity compared with a control condition of diabetes support and education (DSE). MEASUREMENTS: Certified examiners who were masked to intervention assignment administered a standard battery of cognitive function tests (Modified Mini-Mental State Examination, Rey Auditory Verbal Learning Test, Digit Symbol Coding, Trail-Making Test, Modified Stroop Color-Word Test) to participants 10 to 13 years after enrollment. RESULTS: Assignment to lifestyle intervention was not associated with significantly different overall (P = .10) or domain-specific (all P > .10) cognitive function than assignment to diabetes support and education. Results were fairly consistent across prespecified groups, but there was some evidence of trends for differential intervention effects showing modest harm in ILI in participants with greater body mass index and in individuals with a history of cardiovascular disease. Cognitive function was not associated with changes in weight or fitness (all P > .05). CONCLUSION: A long-term behavioral weight loss intervention for overweight and obese adults with diabetes mellitus was not associated with cognitive benefit. Trial Registration clinicaltrials.gov Identifier: NCT00017953.
Authors: Jenni Lehtisalo; Jaana Lindström; Tiia Ngandu; Miia Kivipelto; Satu Ahtiluoto; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Johan G Eriksson; Matti Uusitupa; Jaakko Tuomilehto; Jose A Luchsinger Journal: Diabetes Metab Res Rev Date: 2015-08-18 Impact factor: 4.876
Authors: Mark A Espeland; Stephen R Rapp; George A Bray; Denise K Houston; Karen C Johnson; Abbas E Kitabchi; Andrea L Hergenroeder; Jeff Williamson; John M Jakicic; Brent van Dorsten; Stephen B Kritchevsky Journal: J Gerontol A Biol Sci Med Sci Date: 2014-03-11 Impact factor: 6.053
Authors: Rena R Wing; Paula Bolin; Frederick L Brancati; George A Bray; Jeanne M Clark; Mace Coday; Richard S Crow; Jeffrey M Curtis; Caitlin M Egan; Mark A Espeland; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Barbara Harrison; Helen P Hazuda; James O Hill; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Abbas E Kitabchi; William C Knowler; Cora E Lewis; Barbara J Maschak-Carey; Maria G Montez; Anne Murillo; David M Nathan; Jennifer Patricio; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; David Reboussin; Judith G Regensteiner; Amy D Rickman; Donna H Ryan; Monika Safford; Thomas A Wadden; Lynne E Wagenknecht; Delia S West; David F Williamson; Susan Z Yanovski Journal: N Engl J Med Date: 2013-06-24 Impact factor: 91.245
Authors: Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger Journal: Arch Neurol Date: 2009-03
Authors: Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski Journal: Control Clin Trials Date: 2003-10
Authors: Mark A Espeland; Kirk Erickson; Rebecca H Neiberg; John M Jakicic; Thomas A Wadden; Rena R Wing; Lisa Desiderio; Guray Erus; Meng-Kang Hsieh; Christos Davatzikos; Barbara J Maschak-Carey; Paul J Laurienti; Kathryn Demos-McDermott; R Nick Bryan Journal: Diabetes Care Date: 2016-03-29 Impact factor: 19.112
Authors: Mark A Espeland; Owen Carmichael; Kathleen Hayden; Rebecca H Neiberg; Anne B Newman; Jeffery N Keller; Thomas A Wadden; Stephen R Rapp; James O Hill; Edward S Horton; Karen C Johnson; Lynne Wagenknecht; Rena R Wing Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-14 Impact factor: 6.053
Authors: Kathryn Demos McDermott; Samantha E Williams; Mark A Espeland; Kirk Erickson; Rebecca Neiberg; Thomas A Wadden; R Nick Bryan; Lisa Desiderio; Regina L Leckie; Lucy H Falconbridge; John M Jakicic; Miguel Alonso-Alonso; Rena R Wing Journal: Obesity (Silver Spring) Date: 2019-05-21 Impact factor: 5.002
Authors: Kathleen M Hayden; Rebecca H Neiberg; Joni K Evans; José A Luchsinger; Owen Carmichael; Gareth R Dutton; Karen C Johnson; Steven E Kahn; Stephen R Rapp; Sevil Yasar; Mark A Espeland Journal: Dement Geriatr Cogn Disord Date: 2021-08-19 Impact factor: 3.346
Authors: Mark A Espeland; Owen Carmichael; Sevil Yasar; Christina Hugenschmidt; William Hazzard; Kathleen M Hayden; Stephen R Rapp; Rebecca Neiberg; Karen C Johnson; Siobhan Hoscheidt; Michelle M Mielke Journal: Alzheimers Dement Date: 2018-07-05 Impact factor: 21.566
Authors: Mark A Espeland; Gareth R Dutton; Rebecca H Neiberg; Owen Carmichael; Kathleen M Hayden; Karen C Johnson; Robert W Jeffery; Laura D Baker; Delilah R Cook; Dalane W Kitzman; Stephen R Rapp Journal: J Gerontol A Biol Sci Med Sci Date: 2018-10-08 Impact factor: 6.053
Authors: Hussein N Yassine; Andrea Anderson; Roberta Brinton; Owen Carmichael; Mark A Espeland; Siobhan Hoscheidt; Christina E Hugenschmidt; Jeffrey N Keller; Anne Peters; Xavier Pi-Sunyer Journal: Neurobiol Aging Date: 2020-04-08 Impact factor: 4.673
Authors: Sarbani Ghoshal; Subhashis Banerjee; Jinsong Zhang; Michael L Niehoff; Susan A Farr; Andrew A Butler Journal: Peptides Date: 2021-10-22 Impact factor: 3.750
Authors: Owen T Carmichael; Rebecca H Neiberg; Gareth R Dutton; Kathleen M Hayden; Edward Horton; F Xavier Pi-Sunyer; Karen C Johnson; Stephen R Rapp; Adam P Spira; Mark A Espeland Journal: J Clin Endocrinol Metab Date: 2020-12-01 Impact factor: 5.958
Authors: Diana Maria Ariton; Joan Jiménez-Balado; Olga Maisterra; Francesc Pujadas; María José Soler; Pilar Delgado Journal: J Clin Med Date: 2021-05-27 Impact factor: 4.241